Alex Foxman, MD, physician and medical director for Achieve Health and Weight Loss, says, They are exactly the same medication with exactly the same dosing schedule. KFF data indicates that Medicaid spent around $39 million in 2022 covering Wegovy, a similar drug thats approved specifically for obesity treatment
Specifically, the inclusion of the SURPASS-CVOT trial, which compares tirzepatide against dulaglutide rather than semaglutide, is explicitly justified as it provides vital contextual cardiovascular outcome data for tirzepatide in the absence of a completed head-to-head cardiovascular trial between the two primary agents
There are lots of these macronutrients in energy-dense foods, which tend to be foods high in fat or sugars with a low water content
I've continued to microdose, at an even lower dose once I lost the weight
While you might find information online about the benefits of both, only a licensed professional can determine if the combination is safe for your specific body chemistry
For troches, remove from packaging with dry hands